Ether has reclaimed the $3,000 level as large holders accumulate tokens and network activity increases. The combination of whale buying and rising usage metrics is boosting expectations for a potential upside breakout.Ether has reclaimed the $3,000 level as large holders accumulate tokens and network activity increases. The combination of whale buying and rising usage metrics is boosting expectations for a potential upside breakout.

Ether Reclaims $3,000 as Whale Accumulation and Network Activity Surge

2025/12/23 11:08
3 min read
News Brief
Ether has reclaimed the $3,000 level as large holders accumulate tokens and network activity increases. The combination of whale buying and rising usage metrics is boosting expectations for a potential upside breakout.

Growing on-chain metrics fuel expectations of upside breakout

Price Recovery

Ether has reclaimed the $3,000 level as large holders accumulate tokens and network activity increases. The combination of whale buying and rising usage metrics is boosting expectations for a potential upside breakout.

The psychological $3,000 threshold represents an important technical level that bulls have struggled to hold in recent months.

Whale Accumulation

Large wallet addresses have been increasing their Ether holdings, signaling confidence from sophisticated market participants. Whale behavior often precedes significant price movements, as these holders typically possess deeper market insight and longer investment horizons.

On-chain data shows notable inflows to wallets holding substantial Ether balances. This accumulation pattern suggests whales anticipate higher prices ahead and are positioning accordingly.

Network Activity Rises

Ethereum network usage has surged alongside price recovery. Key metrics including transaction counts, active addresses, and gas consumption have increased, indicating genuine demand for blockspace rather than purely speculative activity.

Rising network activity supports Ether's value proposition as the native asset required for all Ethereum transactions. More usage translates to more demand for ETH to pay gas fees, creating fundamental buying pressure.

Breakout Potential

Technical analysts are watching for confirmation of an upside breakout. Sustained trading above $3,000 combined with strong on-chain fundamentals could trigger momentum buying and short liquidations that accelerate upward movement.

However, broader market conditions and Bitcoin's trajectory will likely influence whether Ether can build on current gains. Macro headwinds remain a consideration despite improving Ethereum-specific metrics.

Context

Ether has underperformed Bitcoin during recent market cycles, frustrating holders expecting the second-largest cryptocurrency to catch up. The current confluence of whale accumulation and network growth offers reasons for renewed optimism among Ethereum supporters.

Technical Outlook

From a charting perspective, Ether faces key resistance levels above $3,000 that must be cleared for sustained upward momentum. The $3,200 zone represents the next significant hurdle, with $3,500 serving as a major psychological and technical barrier beyond that.

Support has established around $2,850, providing a floor that buyers have defended during recent pullbacks. A break below this level would undermine the current bullish narrative and potentially trigger a retest of lower support zones.

The relative strength index and moving average convergence divergence indicators are showing improving momentum, though neither has reached overbought territory. This suggests room remains for continued upside before technical exhaustion sets in.

DeFi and Layer 2 Growth

Ethereum's decentralized finance ecosystem continues expanding, with total value locked showing steady growth. Lending protocols, decentralized exchanges, and liquid staking platforms are attracting renewed capital inflows.

Layer 2 scaling solutions including Arbitrum, Optimism, and Base are processing record transaction volumes, demonstrating successful scaling of the Ethereum ecosystem. This activity ultimately settles to Ethereum mainnet, contributing to network security and ETH demand.

The growth of layer 2 networks addresses previous criticisms about Ethereum's high transaction costs, making the network more accessible to retail users while maintaining security guarantees.

Institutional Interest

Spot Ether exchange-traded funds continue attracting attention following their US approval. While inflows have been modest compared to Bitcoin ETFs, the products provide traditional investors with regulated Ethereum exposure.

Institutional adoption of Ethereum extends beyond speculation to include enterprise blockchain applications, tokenization initiatives, and staking services offered by major financial institutions.

Risks to Consider

Despite positive signals, risks remain. Regulatory uncertainty continues affecting crypto markets broadly. Competition from alternative layer 1 blockchains persists, though Ethereum maintains dominant market share in smart contract platforms.

Macroeconomic factors including interest rate decisions and broader risk asset sentiment will influence Ether's trajectory regardless of network-specific fundamentals.

Market Opportunity
SURGE Logo
SURGE Price(SURGE)
$0.03859
$0.03859$0.03859
-2.35%
USD
SURGE (SURGE) Live Price Chart
Disclaimer: The articles published on this page are written by independent contributors and do not necessarily reflect the official views of MEXC. All content is intended for informational and educational purposes only and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC. Cryptocurrency markets are highly volatile — please conduct your own research and consult a licensed financial advisor before making any investment decisions.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03